卡梅德生物科技（天津）有限公司
400-621-6806
服务电话：400-621-6806
地址：天津市武清区国际企业社区A5号楼五层，301700
邮箱：info@kmdbioscience.com
| 产品编号 | KMP2421 |
|---|---|
| 产品名称 | Human CD274 Protein, Fc Tag |
| 产品描述 | The Human CD274 Protein(KMP2421) is produced in HEK293 Cells and the target gene encoding Phe19-Thr239 is expressed with a Fc tag at the C-terminus. |
| 物种 | Human |
| 宿主 | HEK293 Cells |
| 规格 | 50ug, 100ug, 200ug |
| 纯化方式 | Affinity purification |
| 内毒素水平 | <1.0 EU/ug determined by the LAL method |
| 缓冲体系 | 20mM PB, 150mM NaCl, pH7.4 |
| SDS-PAGE |  |
| 功能 | Acts as a backup for CMTM6 to regulate plasma membrane expression of PD-L1/CD274, an immune inhibitory ligand critical for immune tolerance to self and antitumor immunity. May protect PD-L1/CD274 from being polyubiquitinated and targeted for degradation. |
| 产品背景 | CD274, also known as B7-H1 or programmed death ligand 1(PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1(PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers. |
| 保存条件 | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. |
| 说明 | This product is for research use only. |
| 参考文献 | Nature 549:106-110 (2017) |
津公网安备12011402001522号
